SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022650
Filing Date
2024-02-29
Accepted
2024-02-29 07:43:55
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kpti-20231231.htm   iXBRL 10-K 3641153
2 EX-10.28 kpti-ex10_28.htm EX-10.28 100586
3 EX-21.1 kpti-ex21_1.htm EX-21.1 6326
4 EX-23.1 kpti-ex23_1.htm EX-23.1 17563
5 EX-31.1 kpti-ex31_1.htm EX-31.1 10058
6 EX-31.2 kpti-ex31_2.htm EX-31.2 10097
7 EX-32.1 kpti-ex32_1.htm EX-32.1 7730
8 EX-97 kpti-ex97.htm EX-97 27922
9 GRAPHIC img94494609_0.jpg GRAPHIC 209040
10 GRAPHIC img94494609_1.jpg GRAPHIC 767120
11 GRAPHIC img94494609_2.jpg GRAPHIC 291805
  Complete submission text file 0000950170-24-022650.txt   16853272

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kpti-20231231.xsd EX-101.SCH 1996699
99 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20231231_htm.xml XML 2382283
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36167 | Film No.: 24698907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)